Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
680. Lange L. Zu den Tuberkuloseschutzimpfungen in Lübeck. Zeitschr Tuberkulose<br />
1930; 57: 305-10.<br />
681. Schürmann P, Kleinschmidt H. Pathologie und Klinik der Lübecker<br />
Säuglingstuberkuloseerkrankungen. Arbeiten a d Reichsges-Amt 1935; 69: 25-204.<br />
682. Lange L, Pescator H. Bakteriologische Untersuchungen zur Lübecker<br />
Säuglingstuberkulose. Arbeiten a d Reichsges-Amt 1935; 69: 205-305.<br />
683. Hashimoto T. The vaccination, theory <strong>and</strong> practice. BCG. Tokyo: International<br />
Medical Foundation Japan, 1975.<br />
684. Gheorghiu M, Augier J, Lagrange PH. Maintenance <strong>and</strong> control of the French<br />
BCG strain 1173-P2 (primary <strong>and</strong> secondary seed-lots).<br />
81: 281-8.<br />
Bull Inst Pasteur 1983;<br />
685. Behr MA, Small PM. A historical <strong>and</strong> molecular phylogeny of BCG strains.<br />
Vaccine 1999; 17: 915-22.<br />
686. Oettinger T, Jørgensen M, Ladefoged A, Hasløv K, Andersen P. Development<br />
of the Mycobacterium bovis BCG vaccine: review of the historical <strong>and</strong> biochemical<br />
evidence <strong>for</strong> a genealogical tree. Tubercle Lung Dis 1999; 79: 243-50.<br />
687. Behr MA, Schroeder BG, Brinkman JB, Slayden RA, Barry CE, III. A point<br />
mutation in the mma3 gene is responsible <strong>for</strong> impaired methoxymycolic acid production<br />
in Mycobacterium bovis BCG strains obtained after 1927.<br />
2000; 182: 3394-9.<br />
J Bacteriol<br />
688. Lotte A, Wasz-Höckert O, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG<br />
complications. Estimates of the risks among vaccinated subjects <strong>and</strong> statistical<br />
analysis of their main characteristics. Adv Tuberc Res 1984; 21: 107-93.<br />
689. Lotte A, Wasz-Höckert O, Poisson N, Dumitrescu N, Verron M, Couvet E. A<br />
bibliography of the complications of BCG vaccination. A comprehensive list of<br />
the World Literature since the introduction of BCG up to July 1982, supplemented<br />
by over 100 personal communications. Adv Tuberc Res 1984; 21: 194-245.<br />
690. FitzGerald JM. Management of adverse reactions to Bacille Calmette-Guérin<br />
vaccine. Clin Infect Dis 2000; 31(suppl): S75-S76.<br />
691. Lotte A, Wasz-Höckert O, Poisson N, Engbaek H, L<strong>and</strong>mann H, Quast U,<br />
Andrasofszky B, Lugosi L, Vadasz I, Mihailescu P, Sudic D, Pal D. Second<br />
IUATLD study on complications induced by intradermal BCG-vaccination.<br />
Int Union Tuberc Lung Dis 1988; 63(2): 47-59.<br />
Bull<br />
692. Böttiger M, Romanus V, De Verdier C, Boman G. Osteitis <strong>and</strong> other complications<br />
caused by generalized BCG-itis.<br />
Sc<strong>and</strong> 1982; 71: 471-8.<br />
Experiences in Sweden. Acta Paediatr<br />
693. Schopfer K, Matter L, Brunner C, Pagon S, Stanisic M, Baerlocher K. BCG<br />
osteomyelitis. Case report <strong>and</strong> review. Helv Paediat Acta 1982; 37: 73-81.<br />
694. Kröger L, Korppi M, Br<strong>and</strong>er E, Kröger H, Wasz-Höckert O, Bacman A, Rapola J,<br />
Launiala K, Katila ML. Osteitis caused by Bacille Calmette-Guérin vaccination:<br />
a retrospective analysis of 222 cases. J Infect Dis 1995; 172: 574-6.<br />
215